ID

26214

Descrizione

Hypertension in Breast Cancer Patients Receiving Bevacizumab; ODM derived from: https://clinicaltrials.gov/show/NCT00674011

collegamento

https://clinicaltrials.gov/show/NCT00674011

Keywords

  1. 11/10/17 11/10/17 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

11 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT00674011

Eligibility Breast Cancer NCT00674011

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed breast cancer
Descrizione

Breast Carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0678222
must be starting combination treatment with bevacizumab and chemotherapy. treatment may not have already started. patients may receive therapy either on or off of a clinical trial.
Descrizione

Combined Modality Therapy | bevacizumab | Chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009429
UMLS CUI [2]
C0796392
UMLS CUI [3]
C0392920
any number of prior chemotherapy or biological therapy regimens is acceptable.
Descrizione

Prior Chemotherapy Quantity | Biological treatment Quantity

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C1531518
UMLS CUI [2,2]
C1265611
either no history of hypertension, defined as blood pressure <140/90mm hg on no antihypertensive therapy, or medically controlled pre-existing hypertension, defined as blood pressure < 140/90mm hg on one non-angiotensin converting enzyme inhibitor (ace-i) or non-angiotensin receptor blocking (arb) medication.
Descrizione

Hypertensive disease Absent | Blood Pressure | Antihypertensive therapy Absent | Hypertensive disease Pre-existing Controlled | Pharmaceutical Preparations Without Angiotensin-Converting Enzyme Inhibitors | Pharmaceutical Preparations Without Angiotensin II receptor antagonist

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0005823
UMLS CUI [3,1]
C0585941
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0020538
UMLS CUI [4,2]
C2347662
UMLS CUI [4,3]
C2911690
UMLS CUI [5,1]
C0013227
UMLS CUI [5,2]
C0332288
UMLS CUI [5,3]
C0003015
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C0332288
UMLS CUI [6,3]
C0521942
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of uncontrolled hypertension within the previous 6 months
Descrizione

Uncontrolled hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1868885
inability to assess blood pressure or have prolonged blood pressure cuff inflation due to history of bilateral lymph node dissections, presence of an indwelling venous access device, or other condition
Descrizione

Blood pressure assessment Unable | Lymph Node Dissection Bilateral | Venous access device implantation

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1161105
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0242382
UMLS CUI [2,2]
C0238767
UMLS CUI [3]
C1700941
concurrent use of a statin medication
Descrizione

Statins

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0360714
systolic blood pressure < 100mm hg
Descrizione

Systolic Pressure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0871470

Similar models

Eligibility Breast Cancer NCT00674011

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma
Item
histologically or cytologically confirmed breast cancer
boolean
C0678222 (UMLS CUI [1])
Combined Modality Therapy | bevacizumab | Chemotherapy
Item
must be starting combination treatment with bevacizumab and chemotherapy. treatment may not have already started. patients may receive therapy either on or off of a clinical trial.
boolean
C0009429 (UMLS CUI [1])
C0796392 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
Prior Chemotherapy Quantity | Biological treatment Quantity
Item
any number of prior chemotherapy or biological therapy regimens is acceptable.
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1531518 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Hypertensive disease Absent | Blood Pressure | Antihypertensive therapy Absent | Hypertensive disease Pre-existing Controlled | Pharmaceutical Preparations Without Angiotensin-Converting Enzyme Inhibitors | Pharmaceutical Preparations Without Angiotensin II receptor antagonist
Item
either no history of hypertension, defined as blood pressure <140/90mm hg on no antihypertensive therapy, or medically controlled pre-existing hypertension, defined as blood pressure < 140/90mm hg on one non-angiotensin converting enzyme inhibitor (ace-i) or non-angiotensin receptor blocking (arb) medication.
boolean
C0020538 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0005823 (UMLS CUI [2])
C0585941 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0020538 (UMLS CUI [4,1])
C2347662 (UMLS CUI [4,2])
C2911690 (UMLS CUI [4,3])
C0013227 (UMLS CUI [5,1])
C0332288 (UMLS CUI [5,2])
C0003015 (UMLS CUI [5,3])
C0013227 (UMLS CUI [6,1])
C0332288 (UMLS CUI [6,2])
C0521942 (UMLS CUI [6,3])
Item Group
C0680251 (UMLS CUI)
Uncontrolled hypertension
Item
history of uncontrolled hypertension within the previous 6 months
boolean
C1868885 (UMLS CUI [1])
Blood pressure assessment Unable | Lymph Node Dissection Bilateral | Venous access device implantation
Item
inability to assess blood pressure or have prolonged blood pressure cuff inflation due to history of bilateral lymph node dissections, presence of an indwelling venous access device, or other condition
boolean
C1161105 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0242382 (UMLS CUI [2,1])
C0238767 (UMLS CUI [2,2])
C1700941 (UMLS CUI [3])
Statins
Item
concurrent use of a statin medication
boolean
C0360714 (UMLS CUI [1])
Systolic Pressure
Item
systolic blood pressure < 100mm hg
boolean
C0871470 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial